Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 66,650 clinical trials worldwide
Search
Showing 45701-45750 of 66,650 trials
Active filters:
Status: Recruiting
Clinical Trials (66,650)
NCT06218784
A MAD Study to Evaluate the Safety, Tolerability and PK/PD of iN1011-N17 in Healthy Volunteers and PHN Patients.
PHASE1
Recruiting
64 participants
Started: Nov 11, 2022 · Completed: Jul 29, 2024
7 conditions
1 sponsor
1 location
NCT06196606
Effect of Botulinum Toxin Injection Into Upper Esophageal Sphincter in Patients With Medullary Infarction
NA
Recruiting
20 participants
Started: Nov 11, 2022 · Completed: Dec 12, 2024
3 conditions
1 sponsor
1 location
NCT05476770
Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
PHASE1
Recruiting
54 participants
Started: Nov 11, 2022 · Completed: Nov 11, 2027
11 conditions
1 sponsor
31 locations
NCT05625490
Myocardial Perfusion Imaging Galmydar Rest/Stress
EARLY_PHASE1
Recruiting
30 participants
Started: Nov 11, 2022 · Completed: Dec 1, 2025
1 condition
3 sponsors
1 location
NCT05620693
Study of NY-ESO-1 TCR-T in Advanced Soft Tissue Sarcoma
NA
Recruiting
20 participants
Started: Nov 11, 2022 · Completed: Dec 1, 2028
1 condition
1 sponsor
1 location
NCT05498428
A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer
PHASE2
Recruiting
520 participants
Started: Nov 11, 2022 · Completed: Aug 17, 2027
1 condition
1 sponsor
110 locations
NCT05734430
Genetics of Appendix Cancer Study
N/A
Recruiting
700 participants
Started: Nov 11, 2022 · Completed: Nov 30, 2034
15 conditions
1 sponsor
1 location
NCT05590702
French Observational Study of Patients with Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma in Real-World Settings
N/A
Recruiting
1,000 participants
Started: Nov 11, 2022 · Completed: Dec 1, 2032
1 condition
5 sponsors
57 locations
NCT05639907
Miniscrew Stability and Peri-implant Inflammation When Precoated K21 vs Ethanol Control
NA
Recruiting
30 participants
Started: Nov 11, 2022 · Completed: Jun 30, 2028
1 condition
1 sponsor
1 location
NCT05527470
Induction Chemotherapy Followed by IMRT or Concurrent Chemoradiotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma
PHASE3
Recruiting
440 participants
Started: Nov 11, 2022 · Completed: Nov 11, 2027
1 condition
6 sponsors
2 locations
NCT05521802
A Study of C-CAR088 in Patients With Relapsed or Refractory Multiple Myeloma
PHASE1/PHASE2
Recruiting
92 participants
Started: Nov 11, 2022 · Completed: Jul 31, 2037
1 condition
1 sponsor
1 location
NCT05368662
Quality of Life and Quality of Sleep Studies in Children with Home Care Ventilation in the West of France
NA
Recruiting
160 participants
Started: Nov 11, 2022 · Completed: Sep 24, 2026
2 conditions
1 sponsor
1 location
NCT05606068
A Novel Limb Cryocompression System for Prevention of Chemotherapy Induced Peripheral Neuropathy - Expansion Study
NA
Recruiting
80 participants
Started: Nov 11, 2022 · Completed: Nov 30, 2026
1 condition
4 sponsors
2 locations
NCT05524311
Baricitinib in the Treatment of New-onset Juvenile Dermatomyositis (MYOCIT)
PHASE2
Recruiting
16 participants
Started: Nov 10, 2022 · Completed: Sep 30, 2026
1 condition
1 sponsor
13 locations
NCT05270733
Development of Predictive Psoriasis Response Endotypes Using Single Cell Transcriptomics
PHASE4
Recruiting
56 participants
Started: Nov 10, 2022 · Completed: Dec 31, 2026
1 condition
3 sponsors
1 location
NCT05282953
A Phase I/II Dose-escalating Study of the Safety, Tolerability and Efficacy of KIO-301 Administered Intravitreally to Patients With Retinitis Pigmentosa and Choroideremia (ABACUS)
PHASE1/PHASE2
Recruiting
12 participants
Started: Nov 10, 2022 · Completed: Jul 31, 2026
2 conditions
1 sponsor
2 locations
NCT06801262
TreaT-Assay: the New Frontier for the Diagnosis of Acute Rejection in Kidney Transplantation
N/A
Recruiting
150 participants
Started: Nov 10, 2022 · Completed: May 1, 2026
3 conditions
1 sponsor
1 location
NCT05669495
ANNE Vital Sign System Remote Sleep Assessment
N/A
Recruiting
750 participants
Started: Nov 10, 2022 · Completed: Oct 31, 2025
4 conditions
2 sponsors
1 location
NCT05306834
Stopping Cognitive Decline and Dementia by Fighting Covert Cerebral Small Vessel Disease
NA
Recruiting
400 participants
Started: Nov 10, 2022 · Completed: Nov 30, 2027
3 conditions
1 sponsor
2 locations
NCT05635227
Dexamethasone, Olanzapine, Hemodynamics, and Ventilation in Cardiac Surgery
NA
Recruiting
1,200 participants
Started: Nov 10, 2022 · Completed: Feb 29, 2028
2 conditions
1 sponsor
1 location
NCT06435403
SARS-CoV-2 Specific Antibody Responses and Impact for COVID-19 Disease in Ethiopia
N/A
Recruiting
1,000 participants
Started: Nov 10, 2022 · Completed: Feb 28, 2025
3 conditions
3 sponsors
2 locations
NCT06351085
Enhancing Lung Cancer Screening Through Human-Centered Intervention
NA
Recruiting
2,869 participants
Started: Nov 10, 2022 · Completed: Apr 14, 2025
1 condition
1 sponsor
1 location
NCT05456321
CIFASD 5 tDCS and Cognitive Training
NA
Recruiting
70 participants
Started: Nov 10, 2022 · Completed: May 31, 2027
1 condition
1 sponsor
1 location
NCT05754541
Guo's Endovascular Aortic Arch Replacement of Aortic Dissection by WeFlow-Tribranch Endoprothesis: a Multicenter Pilot Study(GRAFT Study)
NA
Recruiting
20 participants
Started: Nov 10, 2022 · Completed: Dec 31, 2025
1 condition
1 sponsor
4 locations
NCT05855668
Phenotyping Patients With Alcohol and Cannabis Use Disorders Using the Addictions Neuroclinical Assessment
NA
Recruiting
400 participants
Started: Nov 10, 2022 · Completed: Dec 31, 2027
2 conditions
3 sponsors
1 location
NCT06203106
NYSCF Scientific Discovery Biobank
N/A
Recruiting
10,000 participants
Started: Nov 10, 2022 · Completed: Nov 10, 2045
29 conditions
1 sponsor
1 location
NCT05756608
Fibrosis in Chronic and Delayed Myocardial Infarction
N/A
Recruiting
180 participants
Started: Nov 10, 2022 · Completed: Nov 10, 2025
3 conditions
1 sponsor
1 location
NCT05580068
Investigation and Validation of a Study Project on Digital Therapy Management of Patients With Arterial Hypertension
NA
Recruiting
100 participants
Started: Nov 10, 2022 · Completed: Oct 31, 2024
2 conditions
1 sponsor
1 location
NCT06122454
A Phase Ic/IIb Study to Evaluate the Efficacy,Safety and Pharmacokinetics of HST in Patients With CHB
PHASE1/PHASE2
Recruiting
48 participants
Started: Nov 10, 2022 · Completed: Dec 30, 2024
3 conditions
2 sponsors
1 location
NCT05393791
Phase II Randomised Controlled Trial of Patient-specific Adaptive vs. Continuous Abiraterone or eNZalutamide in mCRPC
PHASE2
Recruiting
168 participants
Started: Nov 10, 2022 · Completed: Nov 10, 2027
1 condition
3 sponsors
19 locations
NCT05488665
The COMPLETE Treatment of Bifurcation With Two-stent Techniques: Randomized Comparison of Crush Versus Culotte Technique
NA
Recruiting
512 participants
Started: Nov 10, 2022 · Completed: Sep 27, 2028
1 condition
1 sponsor
1 location
NCT05400616
Nasal Microbiota Transfer Therapy in Chronic Rhinosinusitis Without Nasal Polyps (CRSsNP)
NA
Recruiting
60 participants
Started: Nov 10, 2022 · Completed: Dec 31, 2025
1 condition
4 sponsors
3 locations
NCT05124886
Gut Kidney Axis in Enteric Hyperoxaluria
NA
Recruiting
80 participants
Started: Nov 10, 2022 · Completed: Mar 1, 2026
1 condition
2 sponsors
1 location
NCT05533112
Binaural Beat Stimulation to Improve Patient Outcome After Surgery and Anesthesia
NA
Recruiting
120 participants
Started: Nov 10, 2022 · Completed: Oct 31, 2024
2 conditions
1 sponsor
1 location
NCT05718622
Evaluation and Prediction of the Effect of EECP on HR-NICE Patients
NA
Recruiting
100 participants
Started: Nov 10, 2022 · Completed: Nov 30, 2027
1 condition
1 sponsor
1 location
NCT05706454
Phase 2/Phase 3 Study To Evaluate The Efficacy And Safety Of Ramatroban Along With The Standard Of Care In Subjects Hospitalized For COVID Pneumonia
PHASE2/PHASE3
Recruiting
324 participants
Started: Nov 10, 2022 · Completed: May 31, 2026
2 conditions
7 sponsors
7 locations
NCT05092191
Cannabis as a Complementary Treatment in Multiple Sclerosis
PHASE2
Recruiting
250 participants
Started: Nov 10, 2022 · Completed: May 10, 2025
1 condition
3 sponsors
1 location
NCT05625581
Tofatib Treatment for IgG4-related Disease
N/A
Recruiting
40 participants
Started: Nov 10, 2022 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT05744973
Multi-level Predictors of Structural Racism and Discrimination and Associations With Health and Well-being Across the Life Course in Diverse Families
N/A
Recruiting
631 participants
Started: Nov 10, 2022 · Completed: Jan 31, 2028
1 condition
2 sponsors
2 locations
NCT05623020
A Study to Learn About the Effects of the Combination of Elranatamab (PF-06863135), Daratumumab, Lenalidomide or Elranatamab and Lenalidomide Compared With Daratumumab, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for Transplant
PHASE3
Recruiting
966 participants
Started: Nov 10, 2022 · Completed: Nov 29, 2031
1 condition
1 sponsor
73 locations
NCT06277297
Prognotic Role of CMR in Takotsubo Syndrome
N/A
Recruiting
350 participants
Started: Nov 9, 2022 · Completed: Nov 30, 2032
3 conditions
11 sponsors
1 location
NCT05306600
Onco-Genomas Brasil: Mapping Breast and Prostate Cancer in the Brazilian Public Health System
N/A
Recruiting
882 participants
Started: Nov 9, 2022 · Completed: Dec 31, 2026
2 conditions
2 sponsors
19 locations
NCT05340023
Proteomic Pattern Associated With the Diagnosis of Chronic Thromboembolic Pulmonary Hypertension
N/A
Recruiting
120 participants
Started: Nov 9, 2022 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT04589325
Ixekizumab Diabetes Intervention Trial (I-DIT)
PHASE2
Recruiting
127 participants
Started: Nov 9, 2022 · Completed: Dec 31, 2027
1 condition
1 sponsor
17 locations
NCT05616390
Sintilimab Combined With Bevacizumab and Liver Protective Support Therapy in Unresectable Hepatocellular Carcinoma
PHASE2
Recruiting
30 participants
Started: Nov 9, 2022 · Completed: Nov 30, 2025
1 condition
1 sponsor
1 location
NCT05184582
Physical Exercise During Preoperative Chemotherapy for Breast Cancer
NA
Recruiting
712 participants
Started: Nov 9, 2022 · Completed: Jun 30, 2028
1 condition
1 sponsor
13 locations
NCT05509933
Budesonide Prophylaxis for Engraftment Syndrome After Hematopoietic Cell Transplantation
PHASE3
Recruiting
110 participants
Started: Nov 9, 2022 · Completed: Dec 30, 2026
1 condition
1 sponsor
1 location
NCT05452031
A Dyadic Sleep Health Approach for Persons With Alzheimer's Disease and Caregivers
NA
Recruiting
672 participants
Started: Nov 9, 2022 · Completed: Aug 31, 2027
1 condition
3 sponsors
3 locations
NCT05178966
Evaluation of Efficiency of One Day Patient/Caregiver Psychoeducation on the Caregiver's Burden
NA
Recruiting
240 participants
Started: Nov 9, 2022 · Completed: Nov 30, 2025
2 conditions
1 sponsor
1 location
NCT05590689
Radiodynamic Therapy (RDT) With Gliolan in Patients With First Recurrence of Brain Tumor
PHASE1/PHASE2
Recruiting
34 participants
Started: Nov 9, 2022 · Completed: Jan 31, 2027
1 condition
2 sponsors
1 location
Previous
1
More pages
912
913
914
915
916
917
918
More pages
1333
Next